FDC
Back to Balance Sheet
|
FDC Last 5 Year Contingent Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Contingent Liabilities | ₹205 Cr | ₹108 Cr | ₹74 Cr | ₹60 Cr | ₹56 Cr |
What is the latest Contingent Liabilities ratio of FDC ?
| Year | Contingent Liabilities |
|---|---|
| Mar2026 | ₹205 Cr |
| Mar2025 | ₹108 Cr |
| Mar2024 | ₹74 Cr |
| Mar2023 | ₹60 Cr |
| Mar2022 | ₹56 Cr |
How is Contingent Liabilities of FDC Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹205 Cr | 90.20 | |
| Mar2025 | ₹108 Cr | 44.57 | |
| Mar2024 | ₹74 Cr | 24.95 | |
| Mar2023 | ₹60 Cr | 5.77 | |
| Mar2022 | ₹56 Cr | - | |
Compare Contingent Liabilities of peers of FDC
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| FDC | ₹5,746.0 Cr | 1.7% | -0.1% | -24.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹440,398.0 Cr | 0.1% | -0.6% | 15.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹248,664.0 Cr | -0.6% | 8.7% | 53% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹182,738.0 Cr | -0.8% | -1.7% | 34.7% | Stock Analytics | |
| CIPLA | ₹110,794.0 Cr | -0.6% | -4.2% | -12.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹97,749.4 Cr | 2.7% | -0.7% | -12.1% | Stock Analytics | |
FDC Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| FDC | 1.7% |
-0.1% |
-24.7% |
| SENSEX | -0.8% |
-3.8% |
-8.9% |
You may also like the below Video Courses